ArticleDrug design, development and therapy2024

Discovery of a Novel and Potent Dual-Targeting Inhibitor of ATM and HDAC2 Through Structure-Based Virtual Screening for the Treatment of Testicular Cancer.

Yashi Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.